|
Title
|
Published
|
Price
|
|
Aneurysm Flow Modulating Device Market Current Status & Strategic Opportunities
By: Medtech Reports
With ev3 valuing Chestnut Medical Pipeline Embolization Device Technology at $150 million and forecasting a market of $350 million for cerebral flow diversion devices by 2013, the floodgates for innovation in the paradigm-shifting field of
|
more...
|
8/1/2009
|
$6,950.00
|
|
Endovascular Abdominal Aortic Aneurysm Repair Device Market Technology Update & Market Forecast
By: Medtech Reports
The global market for Endovascular Abdominal Aortic Aneurysm (AAA) Repair, which was valued at $820 million in 2008, is expected to reach $1.6 billion by 2015.
Iterative device improvements and introduction of new generations
|
more...
|
2/1/2009
|
$2,450.00
|
|
Drug Eluting Coronary Stents Market Current Situation & Future Outlook
By: Medtech Reports
The market for drug eluting coronary stents is exhibiting clear evidence of recovery with average annual PCI volumes rising by 5% in the US and 4% in Europe. Average penetration rates are also rising in
|
more...
|
2/1/2009
|
$2,450.00
|
|
Endovascular Aneurysm Repair Device Market- Paradigm Shift & Strategic Opportunities
By: Medtech Reports
The global market for endovascular aneurysm repair devices was estimated at $1,750 million in 2008, a growth rate of 17% over its 2007 level of $1,500 million. Over the past five years the market has
|
more...
|
2/1/2009
|
$3,900.00
|
|
Aortic EndoGraft Market Current Situation & Future Outlook
By: Medtech Reports
In September 1990 Juan Parodi performed the first endovascular aortic aneurysm repair in Buenos Aires. Eighteen years later the Market for Endovascular Aortic Stent Grafts (EndoGrafts) touched the one billion dollar mark globally and is
|
more...
|
10/1/2008
|
$2,850.00
|
|
Endovascular Cerebral Aneurysm Repair Market - Current Situation & Future Outlook
By: Medtech Reports
The market for Endovascular Cerebral Aneurysm Repair (ECAR) has grown significantly since its inception in the mid-90s and the devices available for use in such procedures have evolved rapidly since the introduction of Guglielmi Detachable
|
more...
|
7/1/2008
|
$2,950.00
|
|
Drug Eluting Stents Technology & Market Forecasts
By: Medtech Reports
After a difficult year seeing global revenue for drug eluting stents declining to US3.9 billion globally from a peak of US$5.1 billion in 2005, the market for drug-coated stents is getting back on track.
|
more...
|
2/1/2008
|
$1,450.00
|
|
Neuro Stents & Coils: Technology & Market Forecasts
By: Medtech Reports
The market for Neuro-Endovascular Devices which currently stands at $590 million is expected to reach $1.1 billion by 2012.
The increase in use of non-invasive neuro-imaging modalities in the outpatient setting has led
|
more...
|
7/1/2007
|
$950.00
|
|
Abdominal Aortic Aneurysm: Endovascular Technology & Market Forecasts
By: Medtech Reports
It is estimated that approximately 4.5 million people in the developed word are living with an abdominal aortic aneurysm and each year 600,000 new cases are diagnosed.
Patients typically have no symptoms and, when
|
more...
|
7/1/2007
|
$950.00
|
|
Thoracic Aortic Aneurysm and Dissection: Endovascular Technology and Market Forecast
By: Medtech Reports
An estimated 35,000 thoracic aortic surgical and endovascular interventions are performed every year in the developed world (10,000 in the US alone) at a combined cost to individuals, insurance companies and tax payers of $3.5
|
more...
|
4/1/2007
|
$780.00
|
|
Vena Cava Filters - Technology & Market Forecast
By: Medtech Reports
New and more advanced Retrievable Vena Cava Filters have recently been developed and introduced resulting in renewed growth and change of dynamics in this established market.
The majority of traditional Permanent Vena Cava Filters
|
more...
|
7/1/2005
|
$480.00
|
|
Femoro-Popliteal Angioplasty & Stenting - Technology & Market Forecast
By: Medtech Reports
Peripheral Arterial Disease (PAD) of the Femoropopliteal System is a major cause of morbidity and limb loss accounting for over 300,000 amputations in the developed world every year.
Medical therapy is often ineffective and
|
more...
|
6/1/2005
|
$480.00
|
|
Drug Eluting Stents: Technology & Market Forecast
By: Medtech Reports
Latest research findings indicate that drug eluting stents (DES) reduce the need for re-intervention after PTCA to a greater extent than bare metal stents (BMS).
The market for drug eluting stents has shown
|
more...
Search inside this report
|
2/1/2005
|
$480.00
|
|
Carotid Stents - Technology & Market Forecast
By: Medtech Reports
Carotid Angioplasty and Stenting (CAS) has recently emerged as a popular alternative to endarterectomy for the treatment of carotid atherosclerosis. The recent approval, by the FDA, of carotid artery stents has initiated a global market
|
more...
Search inside this report
|
1/1/2005
|
$285.00
|
|
Neuro Stents & Coils - Technology & Market Forecast
By: Medtech Reports
The landscape of management options for cerebral aneurysms is changing fast. Current evidence suggests that coil embolization of unruptured intracranial aneurysms is usually efficacious in obliterating aneurysms and that its safety is similar to that
|
more...
Search inside this report
|
1/1/2005
|
$285.00
|
|
Title
|
Published
|
Price
|
(0 items)
